Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
NICERGOLINE
(4)
Small molecule
Unknown
Unknown
Investigational
Cardiovascular Diseases
NICERGOLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
JCV8365FWN
Molecule Type:
Small molecule
Molecular Formula:
C24H26BrN3O3
Molecular Weight:
484.39
AlogP:
3.91
PSA:
56.59
HBD:
0.0
HBA:
#RotB:
4.0
Source:
POTASSIUM CHLORIDE
(4)
Small molecule
Unknown
INJECTION; ORAL
Approved
Acid-Base Imbalance; Arrhythmias, Cardiac; Electrolytes; Hemorrhage
POTASSIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
660YQ98I10
Molecule Type:
Small molecule
Molecular Formula:
ClK
Molecular Weight:
74.55
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PYRIDOXINE HYDROCHLORIDE
(4)
Small molecule
Supplement
INJECTION
Approved
Anemia; Anemia, Iron-Deficiency; Folic Acid Deficiency
PYRIDOXINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
68Y4CF58BV
Molecule Type:
Small molecule
Molecular Formula:
C8H12ClNO3
Molecular Weight:
205.64
AlogP:
0.08
PSA:
73.58
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ARTENIMOL
(4)
Small molecule
Unknown
Unknown
Approved
Malaria
ARTENIMOL
×
Maximum Phase:
4
First Approval:
None
UNII:
6A9O50735X
Molecule Type:
Small molecule
Molecular Formula:
C15H24O5
Molecular Weight:
284.35
AlogP:
2.19
PSA:
57.15
HBD:
1.0
HBA:
#RotB:
0.0
Source:
METRIZOATE MAGNESIUM
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
METRIZOATE MAGNESIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
V717MS5D5B
Molecule Type:
Small molecule
Molecular Formula:
C24H20I6MgN4O8
Molecular Weight:
1278.17
AlogP:
3.14
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ACETIC ACID
(4)
Small molecule
Unknown
Unknown
Approved
Inflammation
ACETIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Q40Q9N063P
Molecule Type:
Small molecule
Molecular Formula:
C2H4O2
Molecular Weight:
60.05
AlogP:
0.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
LORMETAZEPAM
(4)
Small molecule
Unknown
Unknown
Investigational
Unknown
LORMETAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
GU56C842ZA
Molecule Type:
Small molecule
Molecular Formula:
C16H12Cl2N2O2
Molecular Weight:
335.19
AlogP:
3.13
PSA:
52.9
HBD:
1.0
HBA:
#RotB:
1.0
Source:
VINCAMINE
(4)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
VINCAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
996XVD0JHT
Molecule Type:
Small molecule
Molecular Formula:
C21H26N2O3
Molecular Weight:
354.45
AlogP:
2.95
PSA:
54.7
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ACECLOFENAC
(4)
Small molecule
Cyclooxygenase-2 inhibitor
Unknown
Approved
Arthralgia; Arthritis, Rheumatoid; Myalgia; Osteoarthritis; Rheumatic Diseases; Spondylitis
ACECLOFENAC
×
Maximum Phase:
4
First Approval:
None
UNII:
RPK779R03H
Molecule Type:
Small molecule
Molecular Formula:
C16H13Cl2NO4
Molecular Weight:
354.19
AlogP:
3.91
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
6.0
Source:
MASITINIB
(4)
Small molecule
Fibroblast growth factor receptor 3 inhibitor
Unknown
Investigational
Neoplasms
MASITINIB
×
Maximum Phase:
4
First Approval:
None
UNII:
M59NC4E26P
Molecule Type:
Small molecule
Molecular Formula:
C28H30N6OS
Molecular Weight:
498.66
AlogP:
5.26
PSA:
73.39
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LOFEPRAMINE
(4)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
LOFEPRAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
OCA4JT7PAW
Molecule Type:
Small molecule
Molecular Formula:
C26H27ClN2O
Molecular Weight:
418.97
AlogP:
5.78
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
7.0
Source:
PINAVERIUM
(4)
Small molecule
Unknown
Unknown
Approved
Digestive System Diseases
PINAVERIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
U2368VVE7O
Molecule Type:
Small molecule
Molecular Formula:
C26H41BrNO4+
Molecular Weight:
511.52
AlogP:
5.29
PSA:
36.92
HBD:
0.0
HBA:
#RotB:
10.0
Source:
AMINOBENZOIC ACID
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
AMINOBENZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
TL2TJE8QTX
Molecule Type:
Small molecule
Molecular Formula:
C7H7NO2
Molecular Weight:
137.14
AlogP:
0.97
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
CARBOCYSTEINE
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
CARBOCYSTEINE
×
Maximum Phase:
4
First Approval:
None
UNII:
740J2QX53R
Molecule Type:
Small molecule
Molecular Formula:
C5H9NO4S
Molecular Weight:
179.2
AlogP:
-0.78
PSA:
100.62
HBD:
3.0
HBA:
#RotB:
5.0
Source:
URETHANE
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
URETHANE
×
Maximum Phase:
4
First Approval:
None
UNII:
3IN71E75Z5
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO2
Molecular Weight:
89.09
AlogP:
0.1
PSA:
52.32
HBD:
1.0
HBA:
#RotB:
1.0
Source:
QUININE DIHYDROCHLORIDE
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
QUININE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
8C3EMH7D9X
Molecule Type:
Small molecule
Molecular Formula:
C20H26Cl2N2O2
Molecular Weight:
397.35
AlogP:
3.17
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FURSULTIAMINE
(4)
Small molecule
Supplement
Unknown
Approved
Unknown
FURSULTIAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
05J61265PX
Molecule Type:
Small molecule
Molecular Formula:
C17H26N4O3S2
Molecular Weight:
398.55
AlogP:
2.5
PSA:
101.57
HBD:
2.0
HBA:
#RotB:
10.0
Source:
SORIVUDINE
(4)
Small molecule
DNA polymerase catalytic subunit inhibitor
Unknown
Investigational
Unknown
SORIVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
C7VOZ162LV
Molecule Type:
Small molecule
Molecular Formula:
C11H13BrN2O6
Molecular Weight:
349.14
AlogP:
-1.49
PSA:
124.78
HBD:
4.0
HBA:
#RotB:
3.0
Source:
ZOTEPINE
(4)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
ZOTEPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
U29O83JAZW
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClNOS
Molecular Weight:
331.87
AlogP:
4.88
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
4.0
Source:
CHLORMERODRIN
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
CHLORMERODRIN
×
Maximum Phase:
4
First Approval:
None
UNII:
99T5TWO621
Molecule Type:
Small molecule
Molecular Formula:
C5H11ClHgN2O2
Molecular Weight:
367.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FLUSPIRILENE
(4)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
FLUSPIRILENE
×
Maximum Phase:
4
First Approval:
None
UNII:
C5QA4GLR9M
Molecule Type:
Small molecule
Molecular Formula:
C29H31F2N3O
Molecular Weight:
475.58
AlogP:
5.31
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CLOTIAZEPAM
(4)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
Unknown
Approved
Anxiety
CLOTIAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
ZCN055599V
Molecule Type:
Small molecule
Molecular Formula:
C16H15ClN2OS
Molecular Weight:
318.83
AlogP:
3.78
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ZIMELDINE HYDROCHLORIDE
(4)
Small molecule
Serotonin (5-HT) receptor antagonist
Unknown
Approved
Unknown
ZIMELDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
2T97D1P85R
Molecule Type:
Small molecule
Molecular Formula:
C16H21BrCl2N2O
Molecular Weight:
408.17
AlogP:
3.84
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
4.0
Source:
CEFSULODIN SODIUM
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
CEFSULODIN SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
2D087186PY
Molecule Type:
Small molecule
Molecular Formula:
C22H19N4NaO8S2
Molecular Weight:
554.54
AlogP:
-0.9
PSA:
190.88
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TRIBROMSALAN
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
TRIBROMSALAN
×
Maximum Phase:
4
First Approval:
None
UNII:
6MCE3VTF0O
Molecule Type:
Small molecule
Molecular Formula:
C13H8Br3NO2
Molecular Weight:
449.92
AlogP:
4.93
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BENZOIC ACID
(4)
Small molecule
Unknown
Unknown
Approved
Urinary Tract Infections
BENZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
8SKN0B0MIM
Molecule Type:
Small molecule
Molecular Formula:
C7H6O2
Molecular Weight:
122.12
AlogP:
1.38
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
SODIUM GLUCONATE
(4)
Small molecule
Unknown
Unknown
Approved
Hemorrhage
SODIUM GLUCONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
R6Q3791S76
Molecule Type:
Small molecule
Molecular Formula:
C6H9NaO7
Molecular Weight:
216.12
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PEPPERMINT OIL
(4)
Small molecule
Unknown
Unknown
Investigational
Unknown
PEPPERMINT OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
AV092KU4JH
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLUCOSAMINE SULFATE
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
GLUCOSAMINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
1FW7WLR731
Molecule Type:
Small molecule
Molecular Formula:
C12H28N2O14S
Molecular Weight:
456.42
AlogP:
-3.25
PSA:
116.17
HBD:
5.0
HBA:
#RotB:
1.0
Source:
SOTAGLIFLOZIN
(4)
Small molecule
Sodium/glucose cotransporter 1 inhibitor
Unknown
Investigational
Diabetes Mellitus
SOTAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
None
UNII:
6B4ZBS263Y
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClO5S
Molecular Weight:
424.95
AlogP:
3.17
PSA:
79.15
HBD:
3.0
HBA:
#RotB:
6.0
Source:
BROMAZEPAM
(4)
Small molecule
GABA receptor alpha-2 subunit positive allosteric modulator
Unknown
Approved
Anxiety
BROMAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
X015L14V0O
Molecule Type:
Small molecule
Molecular Formula:
C14H10BrN3O
Molecular Weight:
316.16
AlogP:
2.63
PSA:
54.35
HBD:
1.0
HBA:
#RotB:
1.0
Source:
POLICOSANOL
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
POLICOSANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROSE BENGAL SODIUM
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
ROSE BENGAL SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
956575SN5L
Molecule Type:
Small molecule
Molecular Formula:
C20H2Cl4I4Na2O5
Molecular Weight:
1017.64
AlogP:
9.0
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
2.0
Source:
POTASSIUM BROMIDE
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
POTASSIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
OSD78555ZM
Molecule Type:
Small molecule
Molecular Formula:
BrK
Molecular Weight:
119.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RACECADOTRIL
(4)
Small molecule
Unknown
Unknown
Approved
Unknown
RACECADOTRIL
×
Maximum Phase:
4
First Approval:
None
UNII:
76K53XP4TO
Molecule Type:
Small molecule
Molecular Formula:
C21H23NO4S
Molecular Weight:
385.49
AlogP:
2.98
PSA:
72.47
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AGOMELATINE
(4)
Small molecule
Melatonin receptor agonist
Unknown
Approved
Depressive Disorder
AGOMELATINE
×
Maximum Phase:
4
First Approval:
None
UNII:
137R1N49AD
Molecule Type:
Small molecule
Molecular Formula:
C15H17NO2
Molecular Weight:
243.31
AlogP:
2.53
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
205
206
207
208
209
210
211
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA